1-1 of 1
Blandine Longerey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Clinical, Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of the Safety Run In Part of a Phase II Trial of the Orally Available MEK-Inhibitor MSC1936369 In Patients with Advanced Hematological Malignancies

Farhad Ravandi, MD, Arnaud Pigneux, MD, PhD, Douglas Smith, MD, HerveĢ Dombret, Xavier Thomas, MD, PhD, Hagop M. Kantarjian, MD, Jorge E. Cortes, Daniel J DeAngelo, MD, PhD, Keith W Pratz, MD, Ekaterine Asatiani, MD, Athos Gianella-Borradori, MD, Blandine Longerey, Jean-Luc Harousseau
Journal: Blood
Blood (2010) 116 (21): 3296.
https://doi.org/10.1182/blood.V116.21.3296.3296
Published: 2010